BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takahashi K, Sato Y, Kohisa J, Watanabe J, Sato H, Mizuno K, Hashimoto S, Terai S. Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers. World J Gastrointest Endosc 2016; 8(19): 716-722 [PMID: 27909552 DOI: 10.4253/wjge.v8.i19.716] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang X, Li Y, Sun Y, Zhang M, Guo C, Mirza IA, Li Y. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases. Dig Dis Sci 2018;63:302-11. [DOI: 10.1007/s10620-017-4866-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
2 Horikawa Y, Mizutamari H, Mimori N, Kato Y, Fushimi S, Sato S, Okubo S. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis. Scandinavian Journal of Gastroenterology 2018;53:243-51. [DOI: 10.1080/00365521.2017.1410569] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
3 Talebi Bezmin Abadi A, Yamaoka Y. Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 2018;14:111-7. [DOI: 10.1016/j.jgar.2018.03.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
4 Hirai A, Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S, Kojima Y, Tominaga K, Tokioka S, Higuchi K. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers. Dig Dis Sci. 2018;63:974-981. [PMID: 29464587 DOI: 10.1007/s10620-018-4948-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
5 Yan W, Gu L, Ren W, Ma X, Qin M, Lyu M, Wang S. Recognition of Helicobacter pylori by protein-targeting aptamers. Helicobacter 2019;24:e12577. [PMID: 30950149 DOI: 10.1111/hel.12577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Chen X, Xu MT, Wen JB. Meta-analysis of vonoprazan and proton pump inhibitors in preventing delayed bleeding and facilitating ulcer healing after gastric endoscopic submucosal dissection. Shijie Huaren Xiaohua Zazhi 2020; 28(24): 1249-1260 [DOI: 10.11569/wcjd.v28.i24.1249] [Reference Citation Analysis]
7 Toya Y, Endo M, Sugai K, Yamada S, Oizumi T, Morishita T, Akasaka R, Yanai S, Nakamura S, Eizuka M, Uesugi N, Sugai T, Matsumoto T. Protective effect of proton pump inhibitors and potassium competitive acid blockers against post-gastric endoscopic submucosal dissection bleeding: a single-center, propensity score-matched analysis. Scand J Gastroenterol 2021;56:199-204. [PMID: 33332216 DOI: 10.1080/00365521.2020.1862906] [Reference Citation Analysis]
8 Martin, Zhou Y, Meng CX, Takagi T, Tian YS. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore) 2020;99:e19357. [PMID: 32118778 DOI: 10.1097/MD.0000000000019357] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Yao T, Watanabe S. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia. J Int Med Res 2019;47:1441-52. [PMID: 30816056 DOI: 10.1177/0300060519828514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Martin, Zhou Y, Meng CX, Takagi T, Tian YS. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore) 2019;98:e14381. [PMID: 30813139 DOI: 10.1097/MD.0000000000014381] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kim EH, Park SW, Nam E, Lee JG, Park CH. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis. Surg Endosc 2019;33:1271-83. [PMID: 30167955 DOI: 10.1007/s00464-018-6409-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Gao H, Li L, Zhang C, Tu J, Geng X, Wang J, Zhou X, Jing J, Pan W. Comparison of efficacy of pharmacological therapies for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and network meta-analysis. Expert Rev Gastroenterol Hepatol 2020;14:207-20. [PMID: 32063071 DOI: 10.1080/17474124.2020.1731304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ishido K, Tanabe S, Azuma M, Katada C, Wada T, Yano T, Koizumi W. Comparison of oral and intravenous lansoprazole for the prevention of bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: a prospective randomized phase II study (KDOG 0802). Surg Endosc 2018;32:2939-47. [PMID: 29273872 DOI: 10.1007/s00464-017-6008-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Bang CS, Shin WG, Seo SI, Choi MH, Jang HJ, Park SW, Kae SH, Yang YJ, Shin SP, Baik GH, Kim HY. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study. Surg Endosc 2019;33:1376-85. [PMID: 30167954 DOI: 10.1007/s00464-018-6412-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kakushima N, Ono H, Takizawa K, Tanaka M, Kawata N, Yoshida M, Murai K, Yabuuchi Y, Kishida Y, Ito S, Imai K, Hotta K, Ishiwatari H, Matsubayashi H. Incidence of Delayed Bleeding among Patients Continuing Antithrombotics during Gastric Endoscopic Submucosal Dissection. Intern Med 2019;58:2759-66. [PMID: 31582592 DOI: 10.2169/internalmedicine.2754-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
16 He HS, Li BY, Chen QT, Song CY, Shi J, Shi B. Comparison of the Use of Vonoprazan and Proton Pump Inhibitors for the Treatment of Peptic Ulcers Resulting from Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis. Med Sci Monit 2019;25:1169-76. [PMID: 30755541 DOI: 10.12659/MSM.911886] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ishii Y, Yamada H, Sato T, Sue S, Kaneko H, Irie K, Sasaki T, Tamura T, Ikeda R, Fukuchi T, Kobayashi R, Makazu M, Sato C, Hirasawa K, Kondo M, Shibata W, Maeda S. Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial. Gastroenterol Res Pract 2018;2018:1615092. [PMID: 29670650 DOI: 10.1155/2018/1615092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
18 Suto D, Yoshida M, Otake T, Ichiishi E, Sato K, Murata K, Ebinuma H, Odaira H, Suzuki Y, Kohgo Y. Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study. Ann Med Surg (Lond) 2020;60:27-30. [PMID: 33101669 DOI: 10.1016/j.amsu.2020.10.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ban H, Inatomi O, Murata M, Otsuka T, Oi M, Matsumoto H, Bamba S, Andoh A. Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study. J Clin Biochem Nutr 2021;68:259-63. [PMID: 34025030 DOI: 10.3164/jcbn.20-143] [Reference Citation Analysis]
20 Ko J, Kim SJ, Kang DH, Choi CW, Kim HW, Park SB. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study. Medicine (Baltimore) 2019;98:e15701. [PMID: 31096515 DOI: 10.1097/MD.0000000000015701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
21 Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018;30:1416-21. [DOI: 10.1097/meg.0000000000001204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
22 Chen JX, Wang JX. Lansoprazole based quadruple therapy for treatment of patients with Helicobacter pylori associated gastric ulcer: Efficacy and impact on serum levels of interferon-γ, interleukin-2, and interleukin-12. Shijie Huaren Xiaohua Zazhi 2018; 26(12): 716-723 [DOI: 10.11569/wcjd.v26.i12.716] [Reference Citation Analysis]
23 Hidaka Y, Imai T, Inaba T, Kagawa T, Omae K, Tanaka S. Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: A cross-design synthesis of randomized and observational studies. PLoS One 2021;16:e0261703. [PMID: 34941937 DOI: 10.1371/journal.pone.0261703] [Reference Citation Analysis]
24 Kang H, Kim BJ, Choi G, Kim JG. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis. Medicine (Baltimore) 2019;98:e15860. [PMID: 31192917 DOI: 10.1097/MD.0000000000015860] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]